McKesson, CD&R Near $5B+ Deal for Option Care Health
MCK sits 27% above its 52-week low of $723.68.
Summary
McKesson and Clayton Dubilier & Rice signed a definitive agreement to acquire Option Care Health for $32.05 per share, a $5.8 billion enterprise value. McKesson will invest $1.4 billion for a 49% stake. This would be McKesson's second major acquisition in recent months, following the $2.25 billion Precision Medicine Group deal in August. The move expands McKesson's presence in infusion services, a high-growth area. The deal would be significant for McKesson, which has a market cap over $100 billion, but the immediate impact on shares may be muted given the company's size. Watch for confirmation of terms and any financing details.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — McKesson and CD&R signed a definitive agreement to acquire Option Care Health for $32.05 per share, a $5.8B enterprise value; McKesson will invest $1.4B for a 49% stake.
At the time of this announcement, MCK was trading at $915.96 on NYSE in the Trade & Services sector, with a market capitalization of approximately $106.7B. The 52-week trading range was $723.68 to $999.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.